Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
Identifieur interne : 000155 ( Main/Exploration ); précédent : 000154; suivant : 000156Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
Auteurs : Harpreet K. Lota [Royaume-Uni] ; Gregory J. Keir [Royaume-Uni] ; David M. Hansell [Royaume-Uni] ; Andrew G. Nicholson [Royaume-Uni] ; Toby M. Maher [Royaume-Uni] ; Athol U. Wells [Royaume-Uni] ; Elisabetta A. Renzoni [Royaume-Uni]Source :
- Thorax [ 0040-6376 ] ; 2013-08.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Alvéolite allergique extrinsèque (diagnostic), Alvéolite allergique extrinsèque (physiopathologie), Alvéolite allergique extrinsèque (traitement médicamenteux), Anticorps monoclonaux d'origine murine (usage thérapeutique), Antigènes CD20 (MeSH), Biopsie (MeSH), Capacité vitale (MeSH), Facteurs immunologiques (usage thérapeutique), Femelle (MeSH), Humains (MeSH), Poumon (anatomopathologie), Poumon (physiopathologie), Rituximab (MeSH), Tomodensitométrie (MeSH), Études de suivi (MeSH), Évolution de la maladie (MeSH).
- MESH :
- anatomopathologie : Poumon.
- diagnostic : Alvéolite allergique extrinsèque.
- physiopathologie : Alvéolite allergique extrinsèque, Poumon.
- traitement médicamenteux : Alvéolite allergique extrinsèque.
- usage thérapeutique : Anticorps monoclonaux d'origine murine, Facteurs immunologiques.
- Adulte d'âge moyen, Antigènes CD20, Biopsie, Capacité vitale, Femelle, Humains, Rituximab, Tomodensitométrie, Études de suivi, Évolution de la maladie.
English descriptors
- KwdEn :
- Alveolitis, Extrinsic Allergic (diagnosis), Alveolitis, Extrinsic Allergic (drug therapy), Alveolitis, Extrinsic Allergic (physiopathology), Antibodies, Monoclonal, Murine-Derived (therapeutic use), Antigens, CD20 (MeSH), Biopsy (MeSH), Disease Progression (MeSH), Female (MeSH), Follow-Up Studies (MeSH), Humans (MeSH), Immunologic Factors (therapeutic use), Lung (pathology), Lung (physiopathology), Middle Aged (MeSH), Rituximab (MeSH), Tomography, X-Ray Computed (MeSH), Vital Capacity (MeSH).
- MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Murine-Derived, Immunologic Factors.
- diagnosis : Alveolitis, Extrinsic Allergic.
- drug therapy : Alveolitis, Extrinsic Allergic.
- pathology : Lung.
- physiopathology : Alveolitis, Extrinsic Allergic, Lung.
- chemical : Antigens, CD20, Biopsy, Disease Progression, Female, Follow-Up Studies, Humans, Middle Aged, Rituximab, Tomography, X-Ray Computed, Vital Capacity.
Url:
DOI: 10.1136/thoraxjnl-2013-203265
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C87
- to stream Istex, to step Curation: 000C87
- to stream Istex, to step Checkpoint: 000003
- to stream PubMed, to step Corpus: 000032
- to stream PubMed, to step Curation: 000032
- to stream PubMed, to step Checkpoint: 000035
- to stream Ncbi, to step Merge: 000275
- to stream Ncbi, to step Curation: 000275
- to stream Ncbi, to step Checkpoint: 000275
- to stream Main, to step Merge: 000156
- to stream Main, to step Curation: 000155
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment</title><author><name sortKey="Lota, Harpreet K" sort="Lota, Harpreet K" uniqKey="Lota H" first="Harpreet K" last="Lota">Harpreet K. Lota</name></author><author><name sortKey="Keir, Gregory J" sort="Keir, Gregory J" uniqKey="Keir G" first="Gregory J" last="Keir">Gregory J. Keir</name></author><author><name sortKey="Hansell, David M" sort="Hansell, David M" uniqKey="Hansell D" first="David M" last="Hansell">David M. Hansell</name></author><author><name sortKey="Nicholson, Andrew G" sort="Nicholson, Andrew G" uniqKey="Nicholson A" first="Andrew G" last="Nicholson">Andrew G. Nicholson</name></author><author><name sortKey="Maher, Toby M" sort="Maher, Toby M" uniqKey="Maher T" first="Toby M" last="Maher">Toby M. Maher</name></author><author><name sortKey="Wells, Athol U" sort="Wells, Athol U" uniqKey="Wells A" first="Athol U" last="Wells">Athol U. Wells</name></author><author><name sortKey="Renzoni, Elisabetta A" sort="Renzoni, Elisabetta A" uniqKey="Renzoni E" first="Elisabetta A" last="Renzoni">Elisabetta A. Renzoni</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:309B61DD1E2C84610FCDEA14134552096B3EE043</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1136/thoraxjnl-2013-203265</idno><idno type="url">https://api.istex.fr/document/309B61DD1E2C84610FCDEA14134552096B3EE043/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C87</idno><idno type="wicri:Area/Istex/Curation">000C87</idno><idno type="wicri:Area/Istex/Checkpoint">000003</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000003</idno><idno type="wicri:doubleKey">0040-6376:2013:Lota H:novel:use:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:23515438</idno><idno type="wicri:Area/PubMed/Corpus">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000032</idno><idno type="wicri:Area/PubMed/Curation">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000032</idno><idno type="wicri:Area/PubMed/Checkpoint">000035</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000035</idno><idno type="wicri:Area/Ncbi/Merge">000275</idno><idno type="wicri:Area/Ncbi/Curation">000275</idno><idno type="wicri:Area/Ncbi/Checkpoint">000275</idno><idno type="wicri:Area/Main/Merge">000156</idno><idno type="wicri:Area/Main/Curation">000155</idno><idno type="wicri:Area/Main/Exploration">000155</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment</title><author><name sortKey="Lota, Harpreet K" sort="Lota, Harpreet K" uniqKey="Lota H" first="Harpreet K" last="Lota">Harpreet K. Lota</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Keir, Gregory J" sort="Keir, Gregory J" uniqKey="Keir G" first="Gregory J" last="Keir">Gregory J. Keir</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Hansell, David M" sort="Hansell, David M" uniqKey="Hansell D" first="David M" last="Hansell">David M. Hansell</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Radiology, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Nicholson, Andrew G" sort="Nicholson, Andrew G" uniqKey="Nicholson A" first="Andrew G" last="Nicholson">Andrew G. Nicholson</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Histopathology, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Maher, Toby M" sort="Maher, Toby M" uniqKey="Maher T" first="Toby M" last="Maher">Toby M. Maher</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Wells, Athol U" sort="Wells, Athol U" uniqKey="Wells A" first="Athol U" last="Wells">Athol U. Wells</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Renzoni, Elisabetta A" sort="Renzoni, Elisabetta A" uniqKey="Renzoni E" first="Elisabetta A" last="Renzoni">Elisabetta A. Renzoni</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Thorax</title><title level="j" type="abbrev">Thorax</title><idno type="ISSN">0040-6376</idno><idno type="eISSN">1468-3296</idno><imprint><publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher><date type="published" when="2013-08">2013-08</date><biblScope unit="volume">68</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="780">780</biblScope></imprint><idno type="ISSN">0040-6376</idno></series><idno type="istex">309B61DD1E2C84610FCDEA14134552096B3EE043</idno><idno type="DOI">10.1136/thoraxjnl-2013-203265</idno><idno type="href">thoraxjnl-68-780.pdf</idno><idno type="ArticleID">thoraxjnl-2013-203265</idno><idno type="PMID">23515438</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0040-6376</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alveolitis, Extrinsic Allergic (diagnosis)</term><term>Alveolitis, Extrinsic Allergic (drug therapy)</term><term>Alveolitis, Extrinsic Allergic (physiopathology)</term><term>Antibodies, Monoclonal, Murine-Derived (therapeutic use)</term><term>Antigens, CD20 (MeSH)</term><term>Biopsy (MeSH)</term><term>Disease Progression (MeSH)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>Humans (MeSH)</term><term>Immunologic Factors (therapeutic use)</term><term>Lung (pathology)</term><term>Lung (physiopathology)</term><term>Middle Aged (MeSH)</term><term>Rituximab (MeSH)</term><term>Tomography, X-Ray Computed (MeSH)</term><term>Vital Capacity (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Alvéolite allergique extrinsèque (diagnostic)</term><term>Alvéolite allergique extrinsèque (physiopathologie)</term><term>Alvéolite allergique extrinsèque (traitement médicamenteux)</term><term>Anticorps monoclonaux d'origine murine (usage thérapeutique)</term><term>Antigènes CD20 (MeSH)</term><term>Biopsie (MeSH)</term><term>Capacité vitale (MeSH)</term><term>Facteurs immunologiques (usage thérapeutique)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Poumon (anatomopathologie)</term><term>Poumon (physiopathologie)</term><term>Rituximab (MeSH)</term><term>Tomodensitométrie (MeSH)</term><term>Études de suivi (MeSH)</term><term>Évolution de la maladie (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Murine-Derived</term><term>Immunologic Factors</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Alveolitis, Extrinsic Allergic</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Alvéolite allergique extrinsèque</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Alveolitis, Extrinsic Allergic</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Alvéolite allergique extrinsèque</term><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Alveolitis, Extrinsic Allergic</term><term>Lung</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Alvéolite allergique extrinsèque</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux d'origine murine</term><term>Facteurs immunologiques</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antigens, CD20</term><term>Biopsy</term><term>Disease Progression</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Rituximab</term><term>Tomography, X-Ray Computed</term><term>Vital Capacity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antigènes CD20</term><term>Biopsie</term><term>Capacité vitale</term><term>Femelle</term><term>Humains</term><term>Rituximab</term><term>Tomodensitométrie</term><term>Études de suivi</term><term>Évolution de la maladie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Lota, Harpreet K" sort="Lota, Harpreet K" uniqKey="Lota H" first="Harpreet K" last="Lota">Harpreet K. Lota</name></region><name sortKey="Hansell, David M" sort="Hansell, David M" uniqKey="Hansell D" first="David M" last="Hansell">David M. Hansell</name><name sortKey="Keir, Gregory J" sort="Keir, Gregory J" uniqKey="Keir G" first="Gregory J" last="Keir">Gregory J. Keir</name><name sortKey="Maher, Toby M" sort="Maher, Toby M" uniqKey="Maher T" first="Toby M" last="Maher">Toby M. Maher</name><name sortKey="Nicholson, Andrew G" sort="Nicholson, Andrew G" uniqKey="Nicholson A" first="Andrew G" last="Nicholson">Andrew G. Nicholson</name><name sortKey="Renzoni, Elisabetta A" sort="Renzoni, Elisabetta A" uniqKey="Renzoni E" first="Elisabetta A" last="Renzoni">Elisabetta A. Renzoni</name><name sortKey="Wells, Athol U" sort="Wells, Athol U" uniqKey="Wells A" first="Athol U" last="Wells">Athol U. Wells</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Eau/explor/LotaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000155 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000155 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Eau
|area= LotaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:309B61DD1E2C84610FCDEA14134552096B3EE043
|texte= Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
}}
| This area was generated with Dilib version V0.6.39. |  |